Take these Nutrients to Help Your Liver!

REFERENCES:

1. Milk thistle in liver diseases: past, present, future - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2010. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/20564545 

2. Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination? - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2016. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/26755857 

3. Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2015. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/26367736 

4. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver - PubMed. PubMed. www.ncbi.nlm.nih.gov; 1989. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/2671116/ 

5. Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer - A comprehensive review - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2016. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/27517806 

6. Milk thistle in liver diseases: past, present, future - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2010. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/20564545 

7. Mechanisms of liver damage - PubMed. PubMed. www.ncbi.nlm.nih.gov; 1996. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/9027949 

8. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2017. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/28125040 

9. Hepatoprotective effect of silymarin - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2014. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/24672644 

10. Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination? - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2016. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/26755857 

11. de Avelar CR, Pereira EM, de Farias Costa PR, de Jesus RP, Magalhães de Oliveira LP. Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis - PMC. PubMed Central (PMC). www.ncbi.nlm.nih.gov; 2017. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526770/ 

12. Milk thistle: early seeds of potential - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2013. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/23993379 

13. A Mini Review on the Chemistry and Neuroprotective Effects of Silymarin - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2017. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/28025940 

14. Effect of silymarin on biochemical parameters of oxidative stress in aged and young rat brain - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2009. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/19647779/ 

15. Silymarin ameliorates memory deficits and neuropathological changes in mouse model of high-fat-diet-induced experimental dementia - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2014. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/24866499 

16. A Potential Alternative against Neurodegenerative Diseases: Phytodrugs - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2016. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/26881043 

17. Silymarin attenuated the amyloid β plaque burden and improved behavioral abnormalities in an Alzheimer’s disease mouse model - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2010. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/21071836 

18. Silymarin effect on amyloid-β plaque accumulation and gene expression of APP in an Alzheimer’s disease rat model - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2014. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/24460990 

19. Silibinin: a novel inhibitor of Aβ aggregation - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2011. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/21185897 

20. Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer’s disease - PubMed. PubMed. www.ncbi.nlm.nih.gov; 1992. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/1444880 

21. Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer’s dementia - PubMed. PubMed. www.ncbi.nlm.nih.gov; 1990. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/2178869 

22. Long-term acetyl-L-carnitine treatment in Alzheimer’s disease - PubMed. PubMed. www.ncbi.nlm.nih.gov; 1991. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/1944900 

23. Acetyl-L-carnitine in the treatment of mildly demented elderly patients - PubMed. PubMed. www.ncbi.nlm.nih.gov; 1990. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/2201659 

24. Mental impairment in aging: selection of patients, methods of evaluation and therapeutic possibilities of acetyl-L-carnitine - PubMed. PubMed. www.ncbi.nlm.nih.gov; 1988. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/3229874 

25. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain - PubMed. PubMed. www.ncbi.nlm.nih.gov; 1986. [accessed 8 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/3781687